Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChesnara Regulatory News (CSN)

Share Price Information for Chesnara (CSN)

Share Price is delayed by 15 minutes
Get Live Data
320.00    0.50 (0.16%)
Bid:
319.50
Ask:
321.50
Spread: 2.00 (0.626%)
Market Cap: £738.14m
CSN Live PriceLast checked at - London Stock Exchange

Intraday Chesnara Share Chart

Result of AGM

12 May 2026 14:00

RNS Number : 0210E
Chesnara PLC
12 May 2026
 

 

LEI Number: 213800VFRMBRTSZ3SJ06

 

12th May 2026

 

CHESNARA plc

("Chesnara" or "the Company")

 

 

RESULT OF THE CHESNARA PLC 2026 ANNUAL GENERAL MEETING

 

 

Chesnara plc (CSN.L) announces that the resolutions put to its Annual General Meeting ("AGM") held on 12th May 2026 were duly passed.

 

The results of the AGM, including the total number of votes received for each resolution, were as follows:

 

 

No.

Resolution

Votes

'for'

%

Votes 'against'

%

Total votes validly cast

Votes 'withheld'

1

To receive and adopt the audited accounts for the year ended 31 December 2025

 

122,260,763

99.99%

12,867

0.01%

122,273,630

139,370

2

To approve the Directors' Remuneration Report for the year ended 31 December 2025

122,098,252

99.82%

217,763

0.18%

122,316,015

96,985

3

To approve the Directors' Remuneration Policy

107,012,349

96.54%

3,829,594

3.46%

110,841,943

11,571,057

4

To declare a final dividend of 14.80 pence per ordinary share for the year ended 31 December 2025

122,397,963

99.99%

7,749

0.01%

122,405,712

7,288

5

To re-appoint Steve Murray as a director

122,259,261

99.96%

47,910

0.04%

122,307,171

105,829

6

To re-appoint Carol Hagh as a director

121,066,065

98.98%

1,251,970

1.02%

122,318,035

94,965

7

To re-appoint Gail Tucker as a director

121,010,131

98.94%

1,291,354

1.06%

122,301,485

111,515

8

To re-appoint Luke Savage as a director

120,905,873

98.85%

1,410,272

1.15%

122,316,145

96,855

9

To re-appoint Eamonn Flanagan as a director

122,139,028

99.86%

177,117

0.14%

122,316,145

96,855

10

To re-appoint Tom Howard as a director

122,246,792

99.94%

69,353

0.06%

122,316,145

96,855

11

To appoint Sam Tymms as a director

122,185,248

99.92%

102,883

0.08%

122,288,131

124,869

12

To re-appoint Deloitte LLP as auditor

121,859,348

99.58%

513,074

0.42%

122,372,422

40,578

13

To authorise the directors to determine the auditor's remuneration

122,067,088

99.75%

310,793

0.25%

122,377,881

35,119

14

To provide limited authority to make political donations and to incur limited political expenditure

121,281,460

99.12%

1,080,771

0.88%

122,362,231

50,769

15

To authorise the directors to allot shares up to a specified amount

121,399,225

99.20%

982,392

0.80%

122,381,617

31,383

16

Special resolution - To authorise the directors to disapply pre-emption rights (general corporate purposes)

110,413,593

90.24%

11,938,347

9.76%

122,351,940

61,060

17

Special resolution - To authorise the directors to disapply pre-emption rights (acquisition or other capital investment)

108,833,019

88.95%

13,518,921

11.05%

122,351,940

61,060

18

Special resolution - To give the Company limited authority to purchase its own shares

122,296,183

99.94%

71,850

0.06%

122,368,033

44,967

19

To authorise the directors to allot ordinary shares in relation to an issue of Restricted Tier 1 Instrument up to a specified amount

122,212,144

99.89%

129,172

0.11%

122,341,316

71,684

20

Special resolution - To authorise the directors to disapply pre-emption rights in relation to the issue of Restricted Tier 1 Instruments

121,934,025

99.66%

409,980

0.34%

122,344,005

68,995

21

Special resolution - To authorise the Company to call general meetings on not less than 14 clear days' notice

120,891,681

98.78%

1,492,919

1.22%

122,384,600

28,400

 

 

The Board is pleased that all resolutions passed with a significant majority.

 

Other Matters

 

The Company's issued share capital on 12th May 2026 consisted of 230,974,321 ordinary shares of 5p each with no shares held in Treasury. Each share carries one voting right and therefore the number of voting rights is 230,974,321.

 

Votes withheld are not a vote in law and have not been counted in the calculation of the votes for and against each resolution or the total votes validly cast.

 

The full text of the resolutions can be found in the Notice of the Annual General Meeting available on the Company's website, www.chesnara.co.uk. In accordance with Listing Rule 9.6.3, full details of the resolutions passed as special business will be submitted to the National Storage Mechanism and will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism .

 

 

For further information, please contact:

 

Investor Enquiries

Sam Perowne

Head of Strategic Development & Investor Relations

Chesnara plc

E - sam.perowne@chesnara.co.uk

 

Media Enquiries

Misha Bayliss - +44 20 7427 5465

Oscar Burnett - +44 20 7427 5435

Teneo

E - chesnara@teneo.com

 

 

Notes to Editors

Chesnara plc (CSN.L) is a FTSE 250 European life, pensions and investment company with specialist expertise in consolidation. We now administer c1.4m policies across the Group's business units of Countrywide Assured and Chesnara Life (formerly HSBC Life (UK) Ltd) in the UK, Scildon in the Netherlands and Movestic in Sweden. Following a three-pillar strategy, Chesnara's primary responsibility is the efficient administration of its customers' life and savings policies, ensuring good customer outcomes and providing a secure and compliant environment to protect policyholder interests. It also adds value by writing focused, profitable new business in the UK, Sweden and the Netherlands and by undertaking value-adding acquisitions of either companies or portfolios. Consistent delivery of the Company strategy has enabled Chesnara to increase its dividend for 21 years in succession.

 

Further details are available on the Company's website (www.chesnara.co.uk).

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGLLLFFQELBBBV
Date   Source Headline
1st Jun 20267:00 amRNSDirector/PDMR Shareholding and Total Voting Rights
29th May 20267:00 amRNSDirector/PDMR Shareholding
27th May 20267:00 amRNSDirector/PDMR Shareholding
19th May 20267:00 amRNSDirector/PDMR Shareholding
14th May 20267:00 amRNSDirector/PDMR Shareholding
12th May 20262:00 pmRNSResult of AGM
1st May 20267:00 amRNSTotal Voting Rights
28th Apr 20267:00 amRNSDirector/PDMR Shareholding
17th Apr 20267:00 amRNSAdmission to Trading
10th Apr 20267:00 amRNSHolding(s) in Company
9th Apr 20267:00 amRNSNotice of AGM
1st Apr 20267:00 amRNSTotal Voting Rights
31st Mar 20267:00 amRNSDirector/PDMR Shareholding
27th Mar 20263:40 pmRNSDirector/PDMR Shareholding
27th Mar 20267:00 amRNSDirector/PDMR Shareholding
26th Mar 20267:00 amRNSDirector/PDMR Shareholding
24th Mar 20267:00 amRNSFinal Results
3rd Mar 20267:00 amRNSTotal Voting Rights
2nd Mar 20267:00 amRNSHolding(s) in Company
27th Feb 20267:00 amRNSUpdated Financial Framework and Notice of Results
17th Feb 20267:00 amRNSAcquisition
2nd Feb 20267:00 amRNSCompletion of HSBC Life (UK) Limited Acquisition
30th Jan 20262:00 pmRNSTotal Voting Rights
31st Dec 20257:00 amRNSTotal Voting Rights
31st Dec 20257:00 amRNSTotal Voting Rights
12th Dec 20251:45 pmRNSRegulatory Approval
12th Dec 20257:00 amRNSChange of Registered Office
9th Dec 20257:00 amRNSHolding(s) in Company
2nd Dec 20257:00 amRNSHolding(s) in Company
7th Nov 20257:00 amRNSTotal Voting Rights
30th Oct 20257:00 amRNSHolding(s) in Company
28th Oct 20257:00 amRNSBlock listing Interim Review
27th Oct 202512:04 pmRNSDirector/PDMR Shareholding
6th Oct 20257:00 amRNSTotal Voting Rights
28th Aug 20257:00 amRNSHalf-year Report
14th Aug 20257:00 amRNSNotice of Interim Results
13th Aug 20256:00 pmRNSPrimary Health Properties
30th Jul 20257:00 amRNS£150 MILLION RESTRICTED TIER 1 BOND ISSUE
28th Jul 20257:00 amRNSDirector/PDMR Shareholding
23rd Jul 202510:52 amRNSResult of Rump Placing
23rd Jul 20258:15 amRNSDirector/PDMR Shareholding
23rd Jul 20257:00 amRNSAnnouncement re: Rights Issue
8th Jul 20257:00 amRNSAdmission of Nil Paid Rights
3rd Jul 202512:10 pmRNSPublication of a Prospectus
3rd Jul 20257:00 amRNSAcquisition & Rights Issue
1st Jul 20257:00 amRNSTotal Voting Rights
17th Jun 20257:00 amRNSDirector/PDMR Shareholding
10th Jun 20257:00 amRNSDirector/PDMR Shareholding
6th Jun 20257:00 amRNSDirectorate Change
23rd May 20257:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.